Bryan Johnson Faces New Challenge: Diagnosed with Autoimmune Gastritis at 48 Amidst $2 Million Longevity Quest

Bryan Johnson, a prominent entrepreneur and biohacker, has gained significant attention for his ambitious efforts to extend human lifespan. Recently, he announced on social media that he has been diagnosed with autoimmune gastritis (AIG), a rare autoimmune condition that gradually attacks the stomach lining. This diagnosis comes as a surprise to many, particularly given Johnson’s extensive commitment to health and longevity, which he pursues through his initiative known as Project Blueprint.

A Unique Approach to Longevity

Johnson has made headlines for his unconventional methods in the quest for longevity. He reportedly invests around $2 million annually in a rigorous health regimen that includes a strictly controlled plant-based diet, a disciplined exercise routine, early bedtimes, and a plethora of medical tests and supplements. His meticulous tracking of health metrics has made his recent diagnosis particularly noteworthy.

Autoimmune gastritis is characterized by the immune system’s attack on the stomach lining, leading to potential nutritional deficiencies and increased cancer risk. Currently, there is no cure for this condition, and management is the only available option.

The Diagnosis and Its Implications

Studies indicate that autoimmune gastritis affects approximately 2 to 5 percent of the global population, although many cases remain undiagnosed due to vague symptoms. For someone like Johnson, who has built a reputation around reversing biological aging and has openly discussed his desire to avoid death, this diagnosis poses a significant challenge.

Johnson’s health journey has not always been focused on longevity. He has spoken candidly about his earlier years, which included a diet high in fast food and sugary drinks. He described his twenties as a period of relative health before his lifestyle choices began to deteriorate, compounded by the pressures of raising a family and managing multiple businesses. During this time, he also dealt with severe chronic depression.

In a statement, Johnson reflected on his health issues, noting that he was diagnosed with hypothyroidism at age 21. He managed this condition for nearly three decades but later recognized that his body had been signaling deeper issues. It wasn’t until May 2026 that he received the autoimmune gastritis diagnosis, which he acknowledged could lead to irreversible damage.

Uncovering the Clues

Johnson identified a long-standing health issue that may have been an early indicator of his autoimmune condition. For over 11 years, he experienced consistently low ferritin levels, a protein responsible for iron storage, despite never developing anemia. His attempts to address this issue were unsuccessful until the AIG diagnosis provided clarity.

Iron deficiency is often one of the earliest warning signs of autoimmune gastritis. However, the disease’s symptoms—such as abdominal pain, nausea, and unexplained weight loss—are common to many digestive disorders, making early identification challenging. Ironically, Johnson’s diagnosis arose during his efforts to enhance his health.

As part of his preparations for a new $1 million longevity initiative called Immortals Care, Johnson underwent extensive testing. While a colonoscopy ruled out cancer, a bidirectional endoscopy and blood tests revealed elevated anti-parietal cell antibodies, indicative of autoimmune gastritis. A subsequent stomach biopsy confirmed early damage to the stomach lining.

A Scientific Challenge Ahead

Johnson and his team view this diagnosis as a scientific challenge. They are closely monitoring his iron levels and other biomarkers while conducting further tests to gain a deeper understanding of the disease. In addition to conventional management strategies, they are exploring experimental therapies targeting immune signaling proteins, regulatory T-cell reconstruction, and engineered cell therapies.

The efficacy of these experimental approaches remains uncertain, as there is currently no cure for autoimmune gastritis. However, Johnson is optimistic about the future of medicine, suggesting that advancements in artificial intelligence, multiomics, and genetic engineering could revolutionize treatment options for conditions previously deemed incurable.

In his own words, Johnson stated, “In the age of AI, multiomics, and custom-built DNA, proteins, and cells, no condition should be presumed incurable simply because no one has yet tried to cure it with today’s stack.”

Johnson’s latest health challenge adds a personal dimension to his ongoing quest for longevity, marking a significant chapter in his journey.

As reported by www.timesnownews.com.

Explore the latest digital editions of FAME Delivered in the Magazine section.

Published on 2026-07-07 13:28:00 • By FAME Delivered News Desk